Eramet Logo
FR0000131757
892800
ERA.PA

Eramet

Caricamento quotazioni...

Previsioni

Acquista
  1
Mantieni
  0
Vendi
  0

  • Eramet reports 54% EBITDA decline and launches comprehensive restructuring plan

    Eramet posts adjusted EBITDA of €372m for 2025 (−54%), a group net loss of €370m and negative adjusted free cash flow of €481m, with net debt of €2,046m (leverage 5.5x); the share fell about 20% after the figures. As countermeasures the company presents a three‑pillar plan: the performance programme ReSolution (target +€130–170m EBITDA within two years), targeted monetisation of assets and a planned €500m capital increase in 2026. Capex in 2026 is also to be cut by 30–40% to €250–290m; operationally Eramet expects slightly higher manganese production and a continued ramp‑up of the Centenario lithium plant to almost 100% capacity by year‑end. The success of the measures, in particular the capital increase and the performance improvements, is considered crucial to restoring investor confidence. » Altro su de.investing.com


  • Eramet shares fall 9.5% after Portzamparc downgrade

    Eramet shares sank 9.5% on Tuesday, recording their biggest one-day loss since October 2024. Portzamparc downgraded the stock from "Hold" to "Reduce" but raised the price target from €48 to €58. The decline marks Eramet’s largest drop in over a year. » Altro su de.investing.com


  • Moody’s downgrades Eramet to B1 with negative outlook

    Moody’s has lowered Eramet’s rating from Ba3 to B1 and kept the outlook negative. The reason is a marked weakening of operating performance due to lower sales volumes, weaker commodity prices, higher costs and delays in ramping up lithium, which led to deteriorations in EBITDA, cash flow and leverage metrics. Moody’s also highlights the risk from concentration in markets with weak institutional strength and a possible export ban on manganese ore in Gabon; nonetheless, Eramet has around €746m in liquidity and an unused revolving credit facility of €935m. » Altro su de.investing.com

Nel 2025, Eramet ha già distribuito +1,50 di dividendi. L'ultimo pagamento è avvenuto a giugno 2025.

Dati finanziari dell'azienda

Nell'ultimo trimestre, Eramet ha registrato ricavi pari a +1,55 Mrd e un utile netto di 195,00 Mio
(EUR) giu 2026
YoY
Ricavi +1,55 Mrd -
Utile lordo 10,00 Mio -
Utile netto 195,00 Mio -
EBITDA +171,00 Mio -

Dati fondamentali

Metrica Valore
Capitalizzazione di mercato
+1,32 Mrd
Numero di azioni
28,50 Mio
Massimo/minimo a 52 settimane
+88,20 - +40,98
Dividendi No
Beta
0,95
Rapporto P/E
2,55
Rapporto PEG
+0,01
Rapporto P/B
+3,00
Rapporto P/S
+0,45

Profilo aziendale

ERAMET S.A. ist als Bergbau- und Metallurgieunternehmen weltweit tätig. Das Unternehmen fördert und verarbeitet Manganerz, Nickelerz und Mineralsande. Außerdem produziert es Ferronickel, hochreines Nickelmetall, Nickelsalze, Nickel- und Kobaltchloride, Nickelkarbonat, Nickel-Ferrolegierungen und andere Metallsalze, die in rostfreiem Stahl, Katalysatoren und Pigmenten sowie legiertem Stahl und Guss verwendet werden; Manganlegierungen wie Ferromangan mit hohem Kohlenstoffgehalt, Silicomangan, Ferromangan mit niedrigem und mittlerem Kohlenstoffgehalt und Silicomangan mit niedrigem Kohlenstoffgehalt zur Verwendung in Batterien, Düngemitteln, Pigmenten, verschiedenen Reagenzien, im Bauwesen und in der Automobilindustrie sowie Mineralsande wie Titandioxid, hochreines Roheisen, Zirkon und Ilmenit zur Verwendung in Keramik und Pigmenten. Darüber hinaus betreibt das Unternehmen die Moanda-Mine in Gabun, Nickelminen in Neukaledonien und Indonesien sowie Mineralsandminen in Senegal und Argentinien. ERAMET S.A. wurde 1880 gegründet und hat seinen Hauptsitz in Paris, Frankreich.

Nome
Eramet
CEO
Christel Bories
Sede centrale Paris, if
Francia
Sito web
Settore
Materiali
Industria
Metalli e attività mineraria
Quotazione in borsa
03/01/2000
Dipendenti 8.561

Simboli di borsa

Borsa Simbolo
Euronext
ERA.PA
Pnk
ERMAF
XETRA
ER7.DE
Frankfurt
ER7.F
Düsseldorf
ER7.DU
London
0MGV.L
Paris
ERA.PA
München
ER7.MU
Wien
ERAM.VI
SIX
ERA.SW
🍪

Parqet  usa i cookie. Scopri di più